Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the best initial therapy for patients with uninvestigated heartburn?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Drossman DA et al. (Eds; 2000) Rome II: Functional gastrointestinal disorders. Diagnosis, pathophysiology, and treatment—A multinational consensus. 2nd ed. McLean, VA: Degnon Associates

    Google Scholar 

  2. Chiba N et al. (2003) The Rome II definition of dyspepsia does not exclude patients with GERD in primary care [abstract #1572] Gastroenterol 124 (Suppl 2): 223–224

    Article  Google Scholar 

  3. Dent J et al. (2004) Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 53 (Suppl 4): S1–S24

    Google Scholar 

  4. van Pinxteren B et al. (2004) Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. The Cochrane Database of Systematic Reviews, Issue 3, Art. No CD002095.pub2

  5. Mason JM et al. (2005) North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther 21: 1135–1143

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brendan C Delaney.

Ethics declarations

Competing interests

BC Delaney has received speaker's honoraria from Astra Zeneca, Wyeth, Takeda, AxCan and Beckitt-Benkiser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delaney, B. What is the best initial therapy for patients with uninvestigated heartburn?. Nat Rev Gastroenterol Hepatol 2, 394–395 (2005). https://doi.org/10.1038/ncpgasthep0262

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0262

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing